Bioqual Inc
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue. It also offers small a… Read more
Market Cap & Net Worth: Bioqual Inc (BIOQ)
Bioqual Inc (PINK:BIOQ) has a market capitalization of $50.09 Million ($50.09 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #27900 globally and #9331 in its home market, demonstrating a -6.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bioqual Inc's stock price $56.00 by its total outstanding shares 894416 (894.42K).
Bioqual Inc Market Cap History: 2015 to 2025
Bioqual Inc's market capitalization history from 2015 to 2025. Data shows growth from $13.46 Million to $50.09 Million (16.54% CAGR).
Bioqual Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bioqual Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.02x
Bioqual Inc's market cap is 1.02 times its annual revenue
0.68x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $24.92 Million | $33.06 Million | $2.88 Million | 0.75x | 8.66x |
| 2017 | $31.81 Million | $36.60 Million | $3.96 Million | 0.87x | 8.03x |
| 2018 | $30.51 Million | $35.88 Million | $3.66 Million | 0.85x | 8.33x |
| 2019 | $39.42 Million | $39.48 Million | $2.83 Million | 1.00x | 13.92x |
| 2020 | $68.95 Million | $46.36 Million | $4.23 Million | 1.49x | 16.30x |
| 2021 | $91.00 Million | $57.68 Million | $6.33 Million | 1.58x | 14.38x |
| 2022 | $72.54 Million | $66.15 Million | $5.26 Million | 1.10x | 13.79x |
| 2023 | $57.24 Million | $62.66 Million | $835.55K | 0.91x | 68.51x |
| 2024 | $60.37 Million | $58.59 Million | $483.48K | 1.03x | 124.87x |
| 2025 | $50.09 Million | $48.87 Million | -$1.05 Million | 1.02x | N/A |
Competitor Companies of BIOQ by Market Capitalization
Companies near Bioqual Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Bioqual Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.34 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #512 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.34 Billion | $586.37 |
| #512 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Bioqual Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Bioqual Inc's market cap moved from $13.46 Million to $ 50.09 Million, with a yearly change of 16.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $50.09 Million | -17.04% |
| 2024 | $60.37 Million | +5.47% |
| 2023 | $57.24 Million | -21.09% |
| 2022 | $72.54 Million | -20.28% |
| 2021 | $91.00 Million | +31.99% |
| 2020 | $68.95 Million | +74.92% |
| 2019 | $39.42 Million | +29.19% |
| 2018 | $30.51 Million | -4.08% |
| 2017 | $31.81 Million | +27.63% |
| 2016 | $24.92 Million | +85.13% |
| 2015 | $13.46 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Bioqual Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $50.09 Million USD |
| MoneyControl | $50.09 Million USD |
| MarketWatch | $50.09 Million USD |
| marketcap.company | $50.09 Million USD |
| Reuters | $50.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.